Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

NCT06016634 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Sickle Cell Anemia
Osteonecrosis
Ischemic Necrosis
Avascular Necrosis

Interventions

DRUG: Alendronate Sodium

Sponsor

University of California, Davis

Collaborators

[object Object]
[object Object]